Kays Al Badawy

Kays Al Badawy began their work experience in 2016 as a Laboratory Technical Assistant at Novabio Diagnostics. In 2017, they worked as a Research Assistant at the University of Strasbourg. The following year, they continued their work as a Research Assistant at the same university. In 2018, they took on the role of Research Assistant at Tessa Therapeutics Ltd, where they optimized T Lymphocytes transduction and TGFb signaling pathway inhibition with decoy receptors. Currently, Kays Al Badawy is a Quality Control Scientist at PDC*line Pharma, where they are responsible for methods development, optimization and validation in the scope of Quality Control activities and PDC*lung101 Clinical Trial Immunomonitoring activities. Kays also performs Quality Control release tests and Stability Studies under GMP conditions, data analysis, batch records review and reports writing, and laboratory and stock management. Additionally, they provide supervision and formation of trainees.

Kays Al Badawy completed a Classes préparatoires aux grandes écoles (CPGE) in Mathematics, Physics, and Chemistry from Lycée Janson-de-Sailly from 2013 to 2015. Kays then earned an Engineer's degree in Chemistry from ECPM Ecole européenne de chimie polymères et matériaux de Strasbourg from 2015 to 2018. Additionally, they earned an Engineer's degree in Biotechnology from ESBS from 2015 to 2018.